Drug or technology
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 20, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; the planned design is rigorous but outcomes remain unknown and unverified.
AUG 19, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1 dose-escalation and dose-expansion trial registration with no results posted; it is a first-in-human safety and tolerability study designed to establish dosing, not efficacy.
AUG 18, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Phase 1 pilot study of a novel dendritic cell vaccine combined with elacestrant in metastatic breast cancer; designed to assess feasibility and safety, not efficacy, with no results yet reported in this registry record.
AUG 14, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 bridging study in a population-specific cohort (Japanese patients) with a surrogate primary endpoint (PFS); results not yet reported in this registry record.
AUG 10, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a recruiting Phase 3 trial registration with no results posted; the study design is rigorous but outcomes are not yet reported, making it a planned intervention study only.
AUG 7, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a Phase 3 trial registration with no posted results; the study is actively recruiting and has not yet generated outcome data.